Title
A Comparison Study of Pain Relief From Dysmenorrhea Between the Vipon Tampon and Ibuprofen
A Randomized Four-Way Crossover Comparison Study of Pain Relief From Dysmenorrhea Between the Vipon Tampon and Ibuprofen
Phase
N/ALead Sponsor
Another Way ProductsStudy Type
InterventionalStatus
Completed Results PostedIndication/Condition
DysmenorrheaStudy Participants
115The purpose of this study is to compare the Vipon tampon with ibuprofen in relieving pain in women with dysmenorrhea. Subjects completed a total of 4 treatment intervals; each subject was randomized to use the VIPON as their treatment for two intervals and Ibuprofen as their treatment for two intervals.
Pain caused by dysmenorrhea can range from mild to severe. At least 50% of all menstruating women experience appreciable pain at some time during their menstruation. An estimated 600 million work hours are lost annually to this affliction with an average loss of time of two or more workdays per year per female employee. Treatment of dysmenorrhea may include either non-pharmacological or pharmacological measures. Pharmacological treatments include oral contraceptives to treat hormonal imbalances, over-the-counter analgesics or non-steroidal anti-inflammatory drugs. The Vipon is a tampon with a small motor unit within, which produces vibratory stimulation. This study aims to provide information on the safety and efficacy of the Vipon in a randomized controlled clinical trial.
The Vipon is a tampon with a small motor unit within, which produces vibratory stimulation, used during menstruation to provide pain relief for women with dysmenorrhea.
400 mg daily
Inclusion Criteria: Females ages >= 18 years 4 consecutive monthly menstrual cycles Self-assessment of dysmenorrhea Non-pregnant status Agrees to use adequate birth control during the trial Consents to use tampons through the test of cure assessment Provides informed consent for participating in the trial Exclusion Criteria: Prohibited use of pain medication 4 hours prior to treatment and during the first 2 hours after treatment with study medication Positive pregnancy test Unwilling or unable to comply with protocol Allergic to ibuprofen
| Event Type | Organ System | Event Term | Study Participants |
|---|
Modified Melzack-McGill Scale measures general pain (0=none, 1-3=mild, 4-6=moderate, 7-9=severe, 10=worst pain) Total Number of Uses Analyzed is a sum of the Number of Uses collected at each time point.
